SONG VAPE has independently developed and produced various concentrations of nicotine. In 2022, SONG VAPE acquired Honghua Biotech to explore the upstream business of producing high-purity nicotine in electronic cigarettes. The nicotine products produced meet the requirements of Good Manufacturing Practice (GMP) for pharmaceuticals (APIs), YC/T 383-2010 standard for China's tobacco industry and USP34-NF29 quality inspection standard of the United States Pharmacopoeia Commission. Ensure high-quality and safe nicotine quality.

SONGVAPE Touching the pulse of the future, the production process has been basically automated, leading the industry. The first-pass rate of the product reaches 99%, 42 inspection procedures and 100% full inspection. Aerospace industry-grade laser welding technology enables the flexibility and compatibility of parts to achieve the best. SONGVAPE will continue to move forward and make continuous efforts to explore a more efficient and safer future of atomized intelligent manufacturing.